Pubdate: Fri, 25 May 2007
Source: Victoria Times-Colonist (CN BC)
Copyright: 2007 Times Colonist
Contact:  http://www.canada.com/victoriatimescolonist/
Details: http://www.mapinc.org/media/481
Author: Peter O'Neil, CanWest News Service

PUBLIC INJECTION SITE LIKELY REDUCES DRUG USE, STUDY FINDS

OTTAWA -- The Harper government's refusal to support North America's 
only legal supervised drug-injection site is driven by ideology and 
politics -- not research, two health scientists said yesterday after 
the release of a new report on the Vancouver facility.

The report, published in a British medical journal, says Insite has 
resulted in a 30 per cent increase in the use of detoxification programs.

This suggests that the site "has probably helped to reduce rates of 
injection drug use among users of the facility," concluded the five 
scientists at the B.C. Centre for Excellence in HIV/AIDS in their 
report, published in the June issue of Addiction.

Health Minister Tony Clement questioned whether research supported 
Insite last September when he refused to grant a 31/2 -year permit extension.

"The government seems intent on ignoring scientific evidence to 
pursue an ideological agenda at the expense of lives in the Downtown 
Eastside," said co-author Dr. Julio Montaner.

He said the new conclusions answer Clement's questions about whether 
Insite is contributing to lower drug use and fighting addiction.

The report said the average number of users entering detox programs 
increased from 21.6 to 31.3 in the year after Insite opened.

"There have been many benefits of Insite in terms of public order and 
reduced HIV risk," said co-author Dr. Evan Wood.

Erik Waddell, a spokesman for Clement, noted yesterday that the 
government has followed through on its commitment to expand research 
on safe injection sites.

Health Canada is commissioning a study costing up to $250,000 to 
analyse health, public order, and operational issues as well as 
"local contextual issues" relating to injection sites.
- ---
MAP posted-by: Beth Wehrman